Approvals/TGA/PRAXOLE XR pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack

Approved

STANDARD

PRAXOLE XR pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6804a8dc90a8472d
Product Name: PRAXOLE XR pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack
Artg Id: 225602
Artg Name: PRAXOLE XR pramipexole dihydrochloride monohydrate 0.75 mg modified release tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2015-06-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

6804a8dc90a8472d

Type

Standard